MAY 08, 2018 09:01 PM PDT

Pure Form of An Illegal Euphoric Drug Treats PTSD

WRITTEN BY: Nouran Amin

 

Post-traumatic stress disorder (PTSD) is a psychiatric disorder where an individual has a difficult time recovering from a traumatic incident often caused by re-occurring memories of the situation leading to mental distress. According to the National co-morbidity published by Harvard Medical School, about 7% of people in the United States will suffer from PTSD during their lifetimes. Although many patients improve with therapy, anti-depressant medications and time, some will continue to have nightmares or flashbacks that persistently allow them to re-live a traumatic event. These patients will often experience severe symptoms that range from triggered anxiety attacks to depression, sleep disturbances, and dramatic changes in mood and behavior.

 

Now, an illegal euphoric drug may seek to treat individuals suffering from PTSD. The pure chemical form or active ingredient of this particular drug is MDMA (3,4-methylenedioxymethamphetamine). MDMA is known to alter mood and perception by targeting brain cells to release the neurohormone serotonin which is a brain chemical that regulates mood, aggression, sexual activity, sleep patterns and pain sensitivity. MDMA is also chemically the same as stimulants and hallucinogens.

Mental health investigators were curious if the chemical proteins of MDMA could be therapeutic for a multitude of metal health disorders. Dr. Michael Mithoefer, M.D., a psychiatrist who studies MDMA-assisted psychotherapy, described MDMA as "unique among drugs that decrease anxiety in that it isn’t sedating and doesn’t impair memory."

"People have clear recall of trauma without being overwhelmed by emotions or dissociating and being emotionally numb," he continues. "Our model is that MDMA is acting as a catalyst to the psychotherapeutic process, not as a stand-along drug."

MDMA was approved by the FDA for classic studies in treating chronic PTSD, but only under certain conditions. Regardless, it was seen that MDMA is the effective choice. “PTSD involves prominent fear responses and the fact that MDMA decreases fear by decreasing activity in the amygdala and increasing activity in prefrontal cortex," explains Mithoefer.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
NOV 18, 2019
Genetics & Genomics
NOV 18, 2019
New Gene Editing Technology to Combat Hereditary Diseases
Until recently, many types of gene-editing methods were unable to target critical parts of DNA. Now however, researchers at the Salk Institute have develop...
NOV 18, 2019
Health & Medicine
NOV 18, 2019
A Skin Patch Might be the Most Effective Melanoma Treatment
Researchers from the Massachusetts Institute of Technology (MIT) have developed a fast-acting skin patch that effectively delivers cancer-fighting medicati...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Triple Drug Combo Extends Fruit Fly Lifespan
A study published in the Proceedings of the National Academy of Sciences (PNAS) suggests that a triple drug combination can extend the lifespan of a fruit ...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
NOV 18, 2019
Neuroscience
NOV 18, 2019
First Drug to Slow Progression of Alzheimer's Shows Promise
An estimated 5.8 million people living in the US have Alzheimer’s disease. Currently, no cure is available and any drugs have only been able to treat...
NOV 18, 2019
Drug Discovery & Development
NOV 18, 2019
How Fluorescent Probes Can Enhance Drug Delivery
Researchers at Cornell University are working on improving the trial-and-error process that is implicated in finding effective molecules for drug delivery....
Loading Comments...